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Abstract
The present work exemplifies how parameter identifiability analysis can be used to gain insights into differences in
experimental systems and how uncertainty in parameter estimates can be handled. The case study, presented here,
investigates interferon-gamma (IFNc) induced STAT1 signalling in two cell types that play a key role in pancreatic cancer
development: pancreatic stellate and cancer cells. IFNc inhibits the growth for both types of cells and may be prototypic of
agents that simultaneously hit cancer and stroma cells. We combined time-course experiments with mathematical
modelling to focus on the common situation in which variations between profiles of experimental time series, from different
cell types, are observed. To understand how biochemical reactions are causing the observed variations, we performed a
parameter identifiability analysis. We successfully identified reactions that differ in pancreatic stellate cells and cancer cells,
by comparing confidence intervals of parameter value estimates and the variability of model trajectories. Our analysis shows
that useful information can also be obtained from nonidentifiable parameters. For the prediction of potential therapeutic
targets we studied the consequences of uncertainty in the values of identifiable and nonidentifiable parameters.
Interestingly, the sensitivity of model variables is robust against parameter variations and against differences between IFNc
induced STAT1 signalling in pancreatic stellate and cancer cells. This provides the basis for a prediction of therapeutic
targets that are valid for both cell types.
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Introduction
Progression of pancreatic cancer (PC) is accelerated by an
extended fibrosis, which has been linked to the activation of
pancreatic stellate cells (PSC) [1–3]. Therefore therapies will be
particularly effective if they simultaneously hit carcinoma and
stroma cells. IFNc acts as an antagonist of PSC activation and
displays inhibitory effects on PC growth by inducing the STAT1
signalling pathway in both cell types [4,5]. While the qualitative
effects of IFNc were the same in cancer and stellate cells, a
quantitative analysis revealed significant differences. Specifically,
IFNc inhibited PSC proliferation more efficiently than tumour cell
growth. The stronger biological effect of IFNc in PSC correlated
with a more pronounced nuclear accumulation of STAT1 in the
stroma cells [4–6], raising the question which molecular mecha-
nisms are underlying these observations.
IFNc-induced STAT1 signalling was investigated by combining
experimental and theoretical systems biology in [5,6]. The same
structure of an ordinary differential equation (ODE) model could be
used for both cell types. The parameter values were estimated from
experimental time series for STAT1 phosphorylation and protein
expression and expression of the STAT1 target gene suppressor of
cytokine signaling 1 (SOCS1) using global optimization.
The present work is motivated by the following consideration:
We observed differences in the trajectories of the parameterized
models describing the IFNc-induced STAT1 signalling pathway in
PSC and cancer cells. Simulation results agreed with the
differences in the experimental time series. The differences can
thus be attributed to unequal parameter values of the two models.
In general, however, one finds a range of parameter sets leading to
a similarly good fit of the model, rather than a unique parameter
set. As a consequence it remains unclear which specific model
parameters are behind the differences observed for the model
trajectories of the two cell types. We therefore focused on the
following two questions:
1) Which reactions cause the differences in the temporal profiles of the model
simulations between PSC and cancer cells?
2) What are the consequences for therapeutic target prediction?
An appropriate method for our first objective is a parameter
identifiability analysis. It investigates how accurate the parameter
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values are determined by the model structure including a mapping
of model variables to observables [7,8] and by the experimental data
[8]. This analysis is necessary because successful parameter
estimation usually results in a range of parameter sets that realise
an equally good agreement between experimental data and model
simulations. In this work, we adopted the approach of [8], which is
based on calculating a confidence interval (CI) for each parameter
value. Consequences of uncertainties in parameter values can be
studied by comparing model trajectories resulting from parameter
sets within the CI [9]. This enabled us to identify those reactions
that are underlying the differences in the model simulations between
both cell types. We therefore exploited the results of parameter
identifiability analysis for a systematic parameter comparison of two
structurally identical mathematical models, which is - to our best
knowledge - the first time such an analysis was conducted.
Note that our approach here is different to typical methods of
model discrimination used in systems biology that compare for two
models with a different number of parameters the quality of the fits to
the same experimental data. These methods investigate whether a
model with more parameters than a default model describes given
data better, without introducing more uncertainty in the parameter
values. Such approaches include Akaike Information Criterion
[10,11], likelihood ratio test for nested models [10–12], Bayesian
model comparison [13] and stimulus design for model selection [14].
In the next part of this work, we investigated the consequences
of parameter uncertainties for the prediction of common
therapeutic targets in both cell types. We performed a sensitivity
analysis to determine those parameters, which sensitively influence
protein concentrations during the time of observation. As a
quantitative measure for sensitivity we employed what is known as
the ‘‘metabolic control coefficient’’ [15,16]. We used our results
from parameter identifiability analysis to select parameter sets for
sensitivity analysis. Sensitive parameters are discussed as candi-
dates for therapeutic targets in both cell types.
It is worth pointing out that we confirmed the key findings of the
study in a larger panel of pancreatic cancer cell lines and in
primary PSC. Finally, we discussed our results from experiments,
parameter identifiability analysis and sensitivity analysis in the
light of STAT1 nuclear accumulation.
Methods
Estimation of parameter values
The parameters of the two models include reaction constants,
delay times, total receptor concentration, Western blot scaling
factors and initial conditions of some model variables. Their values
were estimated by global optimization from protein and mRNA
time series data. We used the experimental findings of reference
[5,6] and additionally raised data of phosphorylated STAT1
translocation in PSC. The additional time series contributed to
stable profile likelihood estimates presented in the ‘‘Results’’ section.
For parameter value estimation a hybrid approach was applied,
which is a combination of a stochastic simulated annealing
algorithm, performing a global search, and a deterministic trust
region algorithm performing a local search. The hybrid approach
is implemented in the routine pwFitBoost of the MATLAB
toolbox PottersWheel [17]. As a measure for how good a
simulation of the model reproduces experimental data, the
following cost function was used:
x2(h)~
Xm
k~1
Xd
l~1
y
exp
kl {y
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k (h)
s
exp
kl
 2
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where h is the parameter vector, yexpkl are the experimental data,
ymodk are values of observables at time points when experimental
data are measured, s
exp
kl is the measurement error of the
experimental data, m is the number of time points and d is the
number of observables [17]. We repeated the parameter value
estimation 50 times and varied the start set of values to ensure that
we approach the global minimum of x2 as close as possible. The
parameter value set for the PSC model and the parameter value
set for the PC model presented in Tables S1, S2, S3 in Text S1
belong to the best fitting sets. For PSC it is the set which leads to
the PLE minimum of k5 and k6 in section ‘‘Results’’. For PC it is
the set with k5~298 min
{1 which is located within the plateau
of the PLE in section ‘‘Results’’.
Due to nonlinearities in the models averages of parameter
values do not necessarily lead to a good fit and are thus not
appropriate quantities for further analysis. Instead of this, a
parameter identifiability analysis provides a confidence interval
with a confidence level for each parameter value.
Parameter identifiability analysis
A parameter identifiability analysis answers the question of how
accurate the parameter values of a given model can be determined
by the experimental data. This in turn allows an investigation of
which model predictions are possible [9]. We apply the data-based
approach by Raue et al. [8], which is based on calculating CIs
defined by a threshold in the profile likelihoods. Following the
authors: ‘‘A parameter is identifiable, if the confidence interval of
its estimate is finite.’’ The approach is summarized below.
The value x2(h
_
) of Eq. (1) corresponds to the maximum
likelihood estimate for Gaussian measurement noise, where h
_
denotes the parameter set of the best fit. Thus we can use x2(h
_
) as
a related expression for the maximum likelihood estimate. Profile
likelihood estimates (PLE) are calculated by iteratively shifting one
parameter from its optimal value by a small value followed by
fitting again the other parameters [8,18]. This procedure
Author Summary
For the prediction of therapeutic targets and the design of
therapies, it is important to study the same pathway across
different cell types. This is particularly relevant for cancer
research, where several cell types are involved in carcino-
genesis. Pancreatic cancer is enhanced by activated
pancreatic stellate cells. It would thus seem plausible for
an effective therapy to hit stellate and cancer cells. The
cytokine IFNc is an inhibitor of proliferation in both cell
types. Antiproliferative effects of IFNc are mediated by
STAT1 signalling. An important aspect is to determine
those reactions that cause the differences in the initial
increase of phosphorylated STAT1 and in the temporal
profile of STAT1 nuclear accumulation between the two
cell types. We examined this aspect by performing a
parameter identifiability analysis for calibrated mathemat-
ical models. We calculated confidence intervals of the
estimated parameter values and found that they provide
insights into reactions underlying the differences. A key
finding of sensitivity analysis elucidated that predicted
targets for enhancement of STAT1 activity are robust
against parameter uncertainty and moreover they are
robust between the two cell types. Our case study
therefore exemplified how identifiability and sensitivity
analysis can provide a basis for the prediction of potential
therapeutic targets.
Parameter Identifiability and Sensitivity Analysis
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continues either until a threshold in the likelihood is met or until a
maximal number of iterations have passed. Based on a likelihood
threshold, a CI for a parameter estimate can be defined [8,19]:
hDx2(h){x2(h
_
)vDa
n o
Da~x
2(a,df ) ð2Þ
The degrees of freedom (df ) give for df~1 the point-wise and
for df~#h the simultaneous CI (#h denotes number of
parameters), both to the confidence level a. We used the
simultaneous CI to assure that the majority of parameters are
within the CI when simulating trajectories. Changing a parameter
value within its CI the model observables stay in agreement with
the experimental noise.
Structural nonidentifiability is caused by a redundant para-
meterisation of the mathematical model. Such correlated param-
eters lead to a curve with the same likelihood value in the high
dimensional landscape of the likelihood function. The CIs are
infinite. Practically nonidentifiability arises if the amount of
experimental data is insufficient with respect to the complexity
of the mathematical model. In that case x2(h) increases by moving
away from the best fit but the CI of the parameter value is infinite
at least in one direction. The x2- curve of a practical
nonidentifiable parameter can be very flat with a minimum
difficult to detect as in our study. The approach of [8] is in contrast
to other published methods, which only allow uncovering
structural nonidentifiability and could be more difficult to apply
for larger nonlinear models [7].
The difference x2(h){x2(h
_
) is equal to the amount of over-
fitting by the parameter set h [20]. To test whether a model shows
deviations from the x2 distribution, random time series are
generated with the same mean and the same standard deviation as
the original data [20,21]. The model is then successively fitted
against all random data sets. Next the optimized parameter values
Figure 1. Reaction network of the IFNc stimulated STAT1 signalling pathway. The network shows key reactions of the pathway. IFNc
activates the type II IFN receptor. To keep the model simple, Janus kinases (JAK) are not considered separately but as part of the active receptor
complex only. The receptor-associated JAKs phosphorylate cytosolic STAT1 (STAT1Uc), followed by rapid and high affinity formation of homodimers
(STAT1Dc). STAT1Dc translocates into the nucleus (STAT1Dn). Nuclear STAT1D can be dephosphorylated, leading to nuclear export of the resulting
STAT1Un into the cytoplasm. STAT1Uc can also shuttle into the nucleus. As a transcription factor, STAT1 induces the transcription of specific target
genes. The network considers STAT1 itself and SOCS1 as target genes of IFNc-activated signalling. SOCS1 is a potential negative feedback regulator;
inhibiting the phosphorylation of STAT1Uc. The annotation delay refers to temporal differences between IFNc action at the receptor level and
consecutive steps. We could omit the binding of nuclear phosphorylated STAT1 to the DNA in this work comparing to [5,6], because the slightly
simplified model leads to indistinguishable fits, as shown in Figures S1 and S2 in Text S1.
doi:10.1371/journal.pcbi.1002815.g001
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for each random data set are used to calculate x2(h) respective to
the original data set according to Eq. (1). Finally, the distribution
of x2(h){x2(h
_
) is compared with a x2 distribution with #h
degrees of freedom. Deviations from a distribution with #h
degrees of freedom indicate that the degrees of freedom of the
model are lower than the number of parameters.
Sensitivity analysis
A sensitivity analysis answers the question how small
perturbations of a single or multiple parameter values influence
the trajectories of arbitrary model variables [22]. For this
analysis, it is irrelevant whether the model parameter values are
arbitrarily chosen or the result from fitting the model to
experimental data.
We are interested in the time-dependent sensitivity of a specific
model variable, as a function of individual model parameter
perturbations. A simple appropriate measure is the metabolic
control coefficient. They measure the relative response of a state
variable xi with respect to the relative perturbation by the
parameter kj and are a standard quantitative measure in sensitivity
analysis [15]. Metabolic control coefficients can be also calculated
for finite times as described in [16]. They are defined by
C(xi(t),kj)~
L logxi(t)
L log kj
ð3Þ
If C(xi(t),kj)~0 then the parameter perturbation has no
influence on the model variable at the respective time point. The
larger the value of C(xi(t),kj) the higher is the influence of the
parameter perturbation. For each parameter the sensitivity
analysis was performed for 20 parameter sets covering the CI.
In each of the 20 sets the value of the default parameter was
perturbed by 21% to calculate the metabolic control coefficient.
This procedure allows to study whether nonidentifiability influ-
ences the results of sensitivity analysis.
Complementary experiments
Cell culture. Immortalised rat PSC [23] were cultured in
Iscove’s modified Dulbecco’s medium (IMDM; Biochrom,
Figure 2. IFNc-induced STAT1 pathway in PSC and PC: Comparison between experimental time series and model simulations.
Experimental time series and model simulations that differ between the two cell types are shown. The left column in Figure 2 contains two subfigures
of Figure S1 in Text S1 and the right column in Figure 2 contains two subfigures of Figure S2 in Text S1 for IFNc=100 ng/ml. The observation time is
given on the x-axis of each subfigure. Experimentally determined expression levels of phospho-STAT1 protein are given in arbitrary units (a.u.).
Immunofluorescence analysis data obtained by confocal microscopy were processed by calculating the ratio of nuclear versus cytoplasmic STAT1
concentration. Measured data are presented as blue circles with error bars. The simulated time courses resulting from the mathematical model with
optimized parameter values are presented by red solid lines. The quality of the fit in the upper right subfigure is commented in the captions of Figure
S2 in Text S1. Experimental time series are replotted from [5,6].
doi:10.1371/journal.pcbi.1002815.g002
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Berlin, Germany) supplemented with 17% fetal calf serum (FCS)
(PAA Laboratories, Pasching, Austria), 1% non-essential amino
acids, 100 U/ml penicillin and 100 mg/ml streptomycin.
Primary rat PSC were isolated as described before [24] and
cultured in IMDM supplemented with 17% FCS, 1% non-
essential amino acids, 100 U/ml penicillin and 100 mg/ml
streptomycin. The PC cell lines BxPC-3, MIA PaCa-2 and
DSL-6A/C1 were obtained from the American Type Culture
Collection (ATCC). BxPC-3 was cultured in RPMI 1640
medium supplemented with 10% FCS, 100 U/ml penicillin
and 100 mg/ml streptomycin. MIA PaCa-2 and DSL-6A/C1
were cultured in Dulbecco’s modified Eagle medium supple-
mented with 10% FCS, 100 U/ml penicillin and 100 mg/ml
streptomycin. The cells were grown at 37uC in a 5% CO2
humidified atmosphere.
Immunofluorescence staining. All cell types were cultured
onto glass coverslips until reaching approximately 20% conflu-
ence. The cells were stimulated with 100 ng/ml species-specific
IFNc (Immunotools, Friesoythe, Germany) for up to 9 hours and
fixed in methanol. Immunofluorescence staining of cytoplasmic
and nuclear STAT1 and phospho-STAT1 as well as confocal laser
scanning microscopy were done as described in [5,6]. Briefly,
images were further analysed using the software ImageJ (Open
Source software package). To quantify nuclear translocation of
STAT1, averaged ratios of nuclear versus cytoplasmic concentra-
tion (sum of pixel intensity divided by area) of STAT1 were
calculated. Therefore, at least 10 cells from three different images
were analysed for each time point.
Results
Experimental data and model simulations reveal
differences between pancreatic stellate and cancer cells
The network presented in Figure 1 shows the key reactions of
the IFNc-induced STAT1 pathway (cf. [5,6]). The network was
translated into a system of ODEs, which is presented in the
supporting information. The simulations of the parameterized
ODE models are in good agreement with the experimental time
series for both cell types (Figures S1 and S2 in Text S1).
Interestingly, the experimental time series and the model
simulations revealed two major differences between PSC and PC
summarized in Figure 2:
A) Rapid initial STAT1 phosphorylation in PSC. Slower initial
rise of phosphorylated STAT1 in PC.
B) Nuclear accumulation of STAT1 in PSC. Lack of nuclear
accumulation of STAT1 in PC.
This raised the question which reactions caused these differ-
ences in the model simulations between PSC and PC. To
approach this question we performed a parameter identifiability
analysis.
Figure 3. Profile likelihood estimates for the calibrated PSCmodel.Model parameters or initial conditions of variables are given on the x-axis
of each subfigure. The PLE (black line) together with the point wise (red dashed lower horizontal line) and simultaneous confidence levels (red
dashed upper horizontal line) are shown on the y-axis. The values of the x-axis where the PLE crosses the confidence levels yield the lower and upper
boundary of the point wise and simultaneous confidence intervals, respectively. A parameter is identifiable if both confidence intervals are finite. We
used the simultaneous confidence levels.
doi:10.1371/journal.pcbi.1002815.g003
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Parameter identifiability analysis
We performed a parameter identifiability analysis by calculating
the profile likelihood estimates (PLE). The PLE for the parameter
values of the PSC model are shown in Figure 3 and the PLE for
the parameter values of the PC model are shown in Figure 4. The
PLE profiles of both cell types show identifiable and nonidentifi-
able parameters.
A distinction between the PSC and PC profiles, important
for our later discussion, is parameter k1 that describes the
receptor activation and parameter k6 that describes nuclear
import of phosphorylated STAT1. The lower boundary of the
CI for the PSC value and the upper boundary of the CI for the
PC value do not overlap and the parameter value at the
minimum is for both k1 and k6 more than ten-fold higher for
the PSC model than for the PC model. In contrast, the
parameter of feedback inhibition (k12) has the same minimal
value for the PSC and PC model but the upper CI is
marginally missed by the PLE for PC. The parameter
describing STAT1 phosphorylation (k4) has a finite lower CI
boundary at around zero for PSC whereas is in unbounded for
PC. The parameter for nuclear export (k10) is identifiable for
PSC but without CI boundaries for PC.
Deviation from x2 distribution. According to Eq. (2) we
calculated the amount of overfitting for the two models. The
comparison between the normalized frequency distribution of
x2(h){x2(h
_
) and the x2 probability distributions with different
degrees of freedom is shown in the upper row of Figure 5 for both
models. We observed deviations between the calculated normalized
frequency distribution and the expected x2df with df~23 for the
PSC and df~24 for the PC model (solid lines). These deviations
could be caused by the nonlinearities in the model and by the small
data sets [20,21]. Reducing the value of df by the number of large-
range correlated parameters leads to df~15 for the PSC model
df~11 for the PC model. However, we still observe deviations
between the calculated x2(h){x2(h
_
) and the expected x2df (dotted
lines) for both models. Therefore we finally chose intermediate
values as ‘‘effective number of degrees of freedom’’ of df~19 for
the PSC model and df~16 for the PC model. Simulations show
that the x2 curve (dashed lines in upper row of Figure 5) and the
histogram over x2(h){x2(h
_
) agree very well.
We furthermore plotted the cumulative distribution function in
the lower part of Figure 5, which allows either calculating
appropriate confidence levels for the given confidence intervals or
alternatively appropriate confidence intervals for the given confi-
dence levels for the estimated parameter values. The calculated CI
led to a higher confidence level a of 86% for the PSC model and of
91% for the PCmodel. For the initial assumption that the degrees of
freedom are equal to the number of parameters the confidence level
was 68%. Alternatively we could have used the expected confidence
intervals with the original confidence levels, which would have not
changed our results of the identifiability analysis.
Reactions which cause differences between the temporal
profiles of PSC and PC. Consequences of uncertainties in
parameter values on the dynamics can be studied by comparing
trajectories resulting from parameter sets within the confidence
Figure 4. Profile likelihood estimates for the calibrated PC model. Model parameters or initial conditions of variables are given on the x-axis
of each subfigure. The PLE (black line) together with the point wise (red dashed lower horizontal line) and simultaneous confidence interval (red
dashed upper horizontal line) are shown on the y-axis. For further details see Figure 3.
doi:10.1371/journal.pcbi.1002815.g004
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interval. In the following, we focus on parameters, which based on
their position in the biochemical network, could be related to the
different experimental profiles of STAT1 and phosphorylated
STAT1 between PSC and PC after stimulation with IFNc.
A) Rapid initial increase of phosphorylated STAT1 time series in
PSC in contrast to PC as presented in Figure 2 - upper row.
i) The estimated value of the parameter k1 (IFNc receptor
activation) is larger in PSC than in PC and the CIs do
not overlap (Figure 6 - upper row). Simulations for
parameter sets within the CI of k1 show that PSC
trajectories for activated receptor (IIr) and phosphory-
lated STAT1 (STAT1D) rapidly increase in contrast to
the respective trajectories for PC, see Figure 6 - second
and third row.
ii) The parameter I (total receptor concentration) is inverse
proportional to k4 (STAT1 phosphorylation) for PSC
and PC, as presented in the upper row of Figure 7. The
correlation equation presented in the respective sub-
figures show that the product k4:I is larger for PSC than
for PC contributing to a more rapid phosphorylation of
STAT1 in PSC.
B) Nuclear accumulation of STAT1 in PSC but not in PC, see
Figure 2 - lower row.
i) The negative correlation between k4 and I contributes to
the small variability of the k4 trajectories for cytoplasmic
and nuclear phosphorylated STAT1 (STAT1Dc,
STAT1Dn) of the PSC model in contrast to the
variability of the PLE trajectories of other parameters,
see Figure 8. The parameters k4 and I are only negatively
correlated for k4w0:01 min21a.u.21 in the PC model.
This leads to a broader variability of the k4 trajectories
resulting from the PC model, see Figure 9.
ii) The parameter k6 describing nuclear import of phos-
phorylated STAT1 is correlated with k5 describing
Figure 5. Amount of overfitting of the calibrated PSC and PC model. Upper figures: Comparison of the normalized frequency distribution
x2(h){x2(h
_
) with the probability distribution x2df . Lower figures: Respective cumulative distributions. The df are chosen to represent the theoretically
expected degrees of freedom (solid line), the degrees of freedom most compatible with the frequency distribution (dashed line) and the calculated
degrees of freedom (dotted line). Left column: results for the calibrated PSC model, right column: results for the calibrated PC model.
doi:10.1371/journal.pcbi.1002815.g005
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nuclear dephosphorylation in the PSC model, see
Figure 7 lower row. The ratio of k6=k5 is nearly equal
to one. This leads to a rapid nuclear accumulation of
phosphorylated STAT1 and to a temporal constant ratio
of nuclear versus cytoplasmic phosphorylated STAT1
(Figure S1 in Text S1, subfigure ‘‘STAT1D immunoflu-
orescence’’). Trajectories, generated from the PLEs of
parameters involved in STAT1 activation, deactivation
and transport (k4, k6, k5, k10), show that IFNc induced
STAT1 phosphorylation is followed by a 3.5-fold
increased nuclear accumulation of phosphorylated
STAT1, relative to the cytoplasm (Figure 8 - lower rows).
The parameter k10 describing nuclear export is identifi-
able and the upper boundary of its CI is smaller than the
lower boundary of the k5-CI (Figure 8 - upper row). This
leads to an accumulation of unphosphorylated STAT1 in
the nucleus which is counterbalanced by enhanced
STAT1 expression at times greater than 200 min. These
reactions together explain the temporal increase with an
initial overshoot of the ratio nuclear versus cytoplasmic
STAT1 for PSC as shown in Figure 2.
iii) The ratio of nuclear versus cytoplasmic STAT1 for PC
does not show a nuclear accumulation of STAT1, as
depicted in Figure 2. The parameter k6 is identifiable, the
best fit value is lower than the best fit value for PSC and
the CIs do not overlap, see the respective PLEs in the
upper row of Figures 8 and 9. Trajectories generated from
the PLEs of parameters involved in STAT1 activation,
deactivation and transport (k4, k6, k5, k10) show that
STAT1 gets phosphorylated but it mainly remains in the
cytoplasm (lower rows in Figure 9). Few trajectories of k5
in Figure 9 which contradict this conclusion base on
values of k6 located outside the upper boundary of its CI.
Figure 7 depicts: For k5w0:25 min21 one finds
k6~0:07 min
21, which is inside the boundaries of the
CI, but for k5v0:25 min21 one finds k6~108 min21
which is located outside the upper boundary of its CI.
Summarizing our results, we successfully identified reactions
that could explain the differences of STAT1 signalling in
pancreatic stellate and cancer cells: A larger value of the reaction
constant for receptor activation (k1) leads to a rapid increase of
STAT1D in PSC and to a slower increase of STAT1D in PC, see
Figures 2 and 6. A larger value of the reaction constant for nuclear
import of phosphorylated STAT1 (k6) leads to a nuclear
accumulation of STAT1 in PSC and to a lack of nuclear
accumulation of STAT1 in PC, as illustrated in Figures 2, 8, and
9.
The parameter identifiability analysis revealed additional
insights into consequences of parameter uncertainties: The
negative correlation between the parameters k4 and I in the
PSC model contributes to the small variability of the k4-
trajectories of STAT1Dc and STAT1Dn. The parameter
describing nuclear export (k10) is identifiable in PSC and the
upper boundary of its CI is smaller than the lower boundary of the
k5-CI. An open question is whether the resulting nuclear
accumulation of STAT1Un supports IFNc action too.
Sensitivity analysis
In this section we investigated the influence of parameter
perturbations on the trajectories of nuclear phosphorylated
STAT1, which we consider as the output of the pathway. We
calculated the metabolic control coefficient for different time
points according to Eq. (3) in order to find out which perturbed
parameters most sensitively influence the temporal profile of
nuclear phosphorylated STAT1 in the PSC and PC model. The
default parameter values are presented in Tables S1, S2, S3 in
Text S1. The calculation was performed for 20 parameter value
sets covering the CI of each default parameter value. The results
for the time-dependent metabolic control coefficients are shown in
Figures 10 and 11. The coefficients with the largest deviation from
the default coefficient form the CI boundaries of the default
coefficient. Interestingly, the temporal profiles of the metabolic
control coefficients for the different parameter values are similar
between the PSC parameter sets (Figure 10) and the PC parameter
sets (Figure 11). The CI boundaries are located close to the default
coefficients in the PSC model. This holds also for most parameters
in the PC model.
The results show that nuclear phosphorylated STAT1 sensi-
tively depends on perturbed parameters describing phosphoryla-
tion (k4), dephosphorylation (k5) and total receptor concentration
Figure 6. Trajectories for parameter sets along profile likeli-
hoods show differences in phosphorylated STAT1 increase. The
upper row shows the PLEs of the parameter k1 from Figures 3 and 4.
The lower rows show trajectories generated from k1-parameter sets
within the PLE confidence intervals of the variables active receptor
concentration (IIr) and phosphorylated STAT1 (STAT1D) for both cell
types stimulated with IFNc= 100 ng/ml. The observation time is given
on the x-axis of each subfigure. The trajectories for k1-parameter sets
are shown on the y-axis. For good visibility approximately 11
trajectories are plotted in equal distance according to the PLE in each
subfigure. A ‘‘2’’ indicates the location of the trajectory for the smallest
parameter value. A ‘‘+’’ indicates the location of the trajectory for the
largest parameter value.
doi:10.1371/journal.pcbi.1002815.g006
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Figure 7. Correlations between model parameters after calculation of the PLEs. The parameter for phosphorylation (k4) is inversely
correlated to the total receptor concentration (I ) for PSC and PC as presented in the upper row. The lower row, left column shows the correlation
between the parameters nuclear dephosphorylation (k5) and nuclear import of STAT1Dc (k6) and for PSC. A respective correlation equation is
inserted in each subfigure. The lower row, right column shows for PC: One finds k6~0:07 min
21 which is located inside the CI for k5w0:25 min21.
However, one finds k6~108 min
21 which is located outside the upper boundary of its CI for k5v0:25 min21.
doi:10.1371/journal.pcbi.1002815.g007
Figure 8. Trajectories for parameter sets along profile likelihoods show nuclear accumulation of phosphorylated STAT1 in PSC. The
upper row shows the PLEs of the parameters (k4, k6, k5, k10) from Figure 3. The lower rows show trajectories generated from (k4, k6, k5, k10)
parameter sets within the PLE confidence intervals of the variables cytoplasmic and nuclear phosphorylated STAT1 (STAT1Dc,STAT1Dn). Stimulation
was done with IFNc= 100 ng/ml. For higher values of k5 and k6 the plateau of the PLE trajectories further decrease, such that for
k6~k5~2:10
6 min21 the plateau is located at STAT1Dc&STAT1Dn&10{7 a.u. For further details see captions of Figure 6.
doi:10.1371/journal.pcbi.1002815.g008
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(I ) over the whole time interval but it is robust against
perturbations of phosphorylated STAT1 nuclear import (k6).
While k4, k5, I are nonidentifiable parameters in both models the
parameter k6 is nonidentifiable in the PSC model but identifiable
in the PC model.
For the control coefficients of the PC model (k9, k10, t1, t2, t3)
the CI boundaries show some deviations from the default control
coefficients leading to a change of sensitivity from medium to
robust. The parameter t1 is identifiable, while the other four
parameters are nonidentifiable.
Summarizing, our results show that there is no clear relation
between parameter identifiability and sensitivity. Note that
parameter identifiability can be improved by additional experi-
ments, while sensitivity only depends on the model properties. An
explanation for the sensitive response of the nonidentifiable
parameters k4, k5, I in the PSC and PC model could be:
Perturbing a parameter value can lead to a very sensitive response
of a model variable. However, parameter identifiability analysis
proceeds by fitting again the other parameter values. This could
lead to very similar or even identical x2 values.
Discussion
Parameter identifiability analysis
Our results of the parameter identifiability analysis led to a
successful identification of model parameters and parameter
relations, explaining differences between the experimental time
series of STAT1 phosphorylation and STAT1 nuclear accumu-
lation for pancreatic stellate cells and pancreatic cancer cells.
We verified whether the normalized frequency distribution
x2(h){x2(h
_
) follows a x2 distribution to test whether the initially
chosen confidence level is consistent with the calculated confidence
intervals for the parameter values according to [20,21]. We
obtained the best agreement for an ‘‘effective number’’ of degrees
of freedom of the x2 distribution, see Figure 5. Based on the
reduced number of degrees of freedom we obtained a higher
confidence level for the calculated confidence intervals of the
parameter value estimates. The calculation of confidence intervals
for the parameter values of the best fit allowed a comparison
between the parameter variability and the variability in the model
trajectories, as presented in Figures 6, 8 and 9. Trajectories for
parameter sets within the confidence interval show:
A) The best fit value of the parameter describing receptor
activation (k1) is larger for the PSC model than for the PC
model and the confidence intervals do not overlap. This
leads to a faster increase of phosphorylated STAT1 in PSC,
compared to PC.
B) The best fit value of the parameter describing nuclear
translocation of phosphorylated STAT1 (k6) is larger for the
PSC model than for the PC model and the confidence
intervals do not overlap. This leads to a high nuclear
accumulation of STAT1 in PSC in contrast to PC.
We successfully answered the first question raised in the
introduction, asking for what causes the differences between the
temporal profiles in pancreatic stellate cells and cancer cells. Our
analysis showed that valuable information for model comparison
can also be obtained from nonidentifiable parameters. Correlated
Figure 9. Trajectories for parameter sets along profile likelihoods show missing nuclear accumulation of phosphorylated STAT1 in
PC. The upper row shows the PLEs of the parameters (k4, k6, k5, k10) from Figure 4. The lower rows show trajectories generated from
(k4, k6, k5, k10) parameter sets within the PLE confidence intervals of the variables cytoplasmic and nuclear phosphorylated STAT1 (STAT1Dc,
STAT1Dn). Stimulation was done with IFNc= 100 ng/ml. A ‘‘*’’ indicates trajectories for k5v0:25 min21. In this region one finds k6~108 min21 (see
Figure 7), which is located outside the upper boundary of its CI. For further details see captions of Figure 6.
doi:10.1371/journal.pcbi.1002815.g009
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parameters and parameters with one finite confidence interval
helped to explain differences between IFNc-induced STAT1
signalling in stellate and cancer cells. This suggests that one should
extend those parameter regions for which a profile likelihood
estimate was calculated, either until a confidence interval
boundary has been reached or until a further calculation is limited
by numerical precision.
We are, however, also aware of the limitations that are due to
parameter nonidentifiabilities in our studied examples. Reducing
practical nonidentifiability, by decreasing the experimental noise,
would improve the differentiation between the parameter sets
(including CI) that fit the PSC time series and the parameter sets
(including CI) that fit the PC time series. A model variable which is
a nonobservable can be influenced by changing a parameter value
even within its CI. This includes the amount of phosphorylated
STAT1 or to answer the question whether there is more nuclear
phosphorylated STAT1 in one of the two cell types. Nevertheless,
we positively exploited information from nonidentifiability in our
work: The knowledge of one finite confidence interval boundary of
a nonidentifiable parameter was sufficient to draw conclusions
about reactions which differ between the IFNc induced STAT1
signalling pathway in pancreatic stellate cells and pancreatic
cancer cells.
Sensitivity analysis
We used the results of the parameter identifiability analysis to
choose parameter sets within the confidence intervals for the
sensitivity analysis. The profiles of the time-dependent meta-
bolic control coefficients are very similar for the PSC parameter
sets and the PC parameter sets as demonstrated in Figures 10
and 11. Though only few parameters turned out to be
identifiable, our study demonstrated that the results from
sensitivity analysis are largely robust for different parameter
sets within the CIs and moreover the results from sensitivity
analysis are largely robust when comparing the two cell types.
Our findings successfully answer the second question raised in
the introduction, asking for the consequences of differences
between the model simulations in pancreatic stellate cells and
cancer cells for therapeutic target prediction. The first outcome
is also in line with Chen et al., who found that for the ErbB1-4
receptors activated MAPK and P13K/Akt pathway in cancer
Figure 10. Time dependent metabolic control coefficients for nuclear phosphorylated STAT1 of PSC model. Stimulation with
IFNc= 100 ng/ml. The observation time is given on the x-axis of each subfigure. The metabolic control coefficient is given on the y-axis. The
symbol ‘‘,’’ in the y-axis label is a placeholder for the respective parameter or initial condition name. Each parameter or initial condition is
independently perturbed by 21%. The metabolic control coefficients for the perturbed default parameter set (See Tables S1, S2, S3 in Text S1)
are shown as red triangles. The black lines show the lower and upper CI boundaries of the MCCs. For few parameters one or both black lines are
behind the red line.
doi:10.1371/journal.pcbi.1002815.g010
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cell types several parameter sets with similar good fits do not
affect sensitivity [25].
Our results show that the time dependent metabolic control
coefficients can be used for experimental therapeutic studies in
cell culture. A similar question was asked by Raia et al., who
predicted that the inhibition of STAT5 phosphorylation in IL13
induced STAT5 pathway reduces proliferation in two lymphoma
cell types [12]. However, in our investigation we need to
enhance STAT1 phosphorylation, in order to ensure a stronger
reduction of proliferation in both cell types [4,5]. An interesting
complement or alternative to this approach is targeting
intracellular components because a higher IFNc dose could
lead to unwanted side effects. A reduction of proliferation by
maximization of nuclear phosphorylated STAT1 could be
achieved by inhibiting nuclear dephosphorylation of STAT1
(k5), SOCS1 transcription (k7), and the feedback regulation (k12)
as depicted in Figures 10 and 11. Inhibition of dephosphoryla-
tion shows an effect over the whole observation time while the
other two processes are sensitive only after a time delay.
Simulations with 50% inhibition of k5 are in agreement with the
results for the metabolic control coefficients with 1% inhibition,
see Figure S3 in Text S1.
Nuclear accumulation of STAT1- bringing the pieces
together
We used mathematical modeling, simulations and parameter
identifiability analysis to explain experimentally observed differ-
ences of IFNc-induced STAT1 signalling in pancreatic stellate
cells and cancer cells. Parameter identifiability analysis revealed
that it is a larger value of the reaction constant for nuclear import
of phosphorylated STAT1 (k6) that leads to a nuclear accumu-
lation of STAT1 in PSC but not in PC.
Subsequently, we expanded our experimental studies to primary
rat PSC and different human PC cell lines, and performed additional
time course experiments. The cells were stimulated with 100 ng/ml
IFNc and STAT1 translocation was observed for nine hours. We
could experimentally confirm the nuclear accumulation of STAT1
after IFNc treatment also for primary PSC, as presented in Figure 12.
In contrast, an extended time series of the PC cell line DSL-6A/C1
showed no nuclear accumulation of STAT1 in response to IFNc.
This result agrees with the shorter time series in Figure 2. A nuclear
accumulation of STAT1 was also not observed in the human PC cell
lines BxPC-3 and MIA PaCa-2 (Figure 12). Our results therefore
allow the conclusion that the differences in IFNc induced nuclear
accumulation of STAT1 are not restricted to the two originally used
Figure 11. Time dependent metabolic control coefficients for nuclear phosphorylated STAT1 of PC model. Stimulation with
IFNc= 100 ng/ml. The observation time is given on the x-axis of each subfigure. The metabolic control coefficient is given on the y-axis. The symbol
‘‘,’’ in the y-axis label is a placeholder for the respective parameter or initial condition name. Each parameter or initial condition is independently
perturbed by 21%. The metabolic control coefficients for the perturbed default parameter set (See Tables S1, S2, S3 in Text S1) are shown as red
triangles.The black lines show the lower and upper CI boundaries of the MCCs. For few parameters one or both black lines are behind the red line.
doi:10.1371/journal.pcbi.1002815.g011
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cell lines but reflect a general difference between pancreatic stellate
and cancer cells. In two previous studies, we could show that nuclear
accumulation of STAT1 is directly correlated with the antiprolifer-
ative effect of IFNc. Accordingly, pancreatic stellate cells were found
to be more sensitive to IFNc-mediated growth inhibition than
pancreatic cancer cells [4,5].
The nuclear accumulation of STAT1 is induced by STAT1
phosphorylation. The parameter identifiability analysis of the ODE
models led to the result that the nuclear import of STAT1D (k6) is a
parameter with a distinct value in the ODE models of PSC and PC,
see Figures 8 and 9, upper row. However, the results of our sensitivity
analysis reveal that the trajectories of nuclear phosphorylated
STAT1, which we consider as output of the pathway, are robust
against perturbations of the parameter k6, see Figures 10 and 11.
Remarkable, the nuclear import of STAT1D cannot be considered
as a target for experimental therapeutic studies in cell culture.
An alternative parameter, which can influence the nuclear
accumulation of STAT1, is the nuclear dephosphorylation (k5).
This parameter is nonidentifiable in the PSC and PC model and the
finite lower CIs do not provide information which parameter value is
larger. However, results of the sensitivity analysis reveal that nuclear
dephosphorylation of STAT1 (k5) is the most sensitive parameter for
both cell types independent of the chosen parameter set within the
CI. The inhibition of k5 leads to a nuclear accumulation of STAT1
over the whole measured period. The parameter describing nuclear
dephosphorylation of STAT1D (k5) can thus be considered as a
target for experimental in vitro therapeutic studies.
Conclusions
We demonstrated that results from parameter identifiability
analysis can be exploited to designate reactions of a signalling
pathway which differ between two cell types. In particular, even
information from nonidentifiable parameters contributed to our
findings. Interestingly, the sensitivity of model variables is robust
against nonidentifiability and moreover it is robust against the
different parameterizations for the two cell types. This enabled us to
predict targets that can be successfully hit in both cell types despite
quantitative and temporal differences in the activation profile of the
signaling cascade. At the current stage, our results and conclusions are
restricted to in vitro models. In the long run, they may also contribute
to the development of drugs that display optimized simultaneous
effects on different types of cells, e.g. in the context of cancer.
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Figure 12. Nuclear accumulation of STAT1 in primary PSC and PC cells. Isolated primary PSC from rat pancreas and PC cell lines of rat (DSL-
6A/C1) and human (BxPC-3, MIA PaCa-2) origin were stimulated with 100 ng/ml species-specific IFNc for the indicated times. STAT1 nuclear
translocation was detected by immunofluorescence analysis. Data obtained by confocal microscopy were processed by calculating the ratio of
nuclear versus cytoplasmic STAT1 concentration. Measured data are presented as circles with error bars, mean (n$10) 6 SEM.
doi:10.1371/journal.pcbi.1002815.g012
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